Search research articles
Contact Us
Filters
Showing results (41-50 of 789) with videos related to
Page
of 79
Sort By:
British Journal of Haematology
|
April 29, 2003
Influence of antithymocyte globulin dose on outcome in cytomegalovirus-seropositive recipients of partially T cell-depleted stem cell grafts from matched-unrelated donors
Ellen Meijer, Adriaan W Dekker, Leo F Verdonck
Clinical Therapeutics
|
January 7, 1998
Factors predicting relapse during maintenance treatment with famotidine in patients with healed reflux esophagitis. Dutch Esophagitis Study Group
I C Wesdorp, W Dekker, H P Festen
Folia Medica Neerlandica
|
January 1, 1971
Pleural metastases of thymoma
J de Jong, W Dekker, A S Groen
Infection
|
May 1, 1983
Colistin and trimethoprim-sulfamethoxazole for the prevention of infection in patients with acute non-lymphocytic leukaemia. Decrease in the emergence of resistant bacteria
M Rozenberg-Arska, A W Dekker, J Verhoef
Clinical Kidney Journal
|
April 17, 2020
A new series of advanced-level research methods papers
Kitty J Jager, Friedo W Dekker, Carmine Zoccali
Klinische Monatsblatter Fur Augenheilkunde
|
May 1, 1996
[Contact glass tonometer]
P W Dekker, H Kanngiesser, Y C Robert
Reviews of Infectious Diseases
|
July 1, 1989
Prevention of infections in granulocytopenic patients by fluorinated quinolones
M Rozenberg-Arska, A W Dekker, J Verhoef
Digestive Diseases and Sciences
|
December 1, 1993
Efficacy of famotidine 20 mg twice a day versus 40 mg twice a day in the treatment of erosive or ulcerative reflux esophagitis
I C Wesdorp, W Dekker, H P Festen
European Journal of Cancer & Clinical Oncology
|
September 1, 1989
Prevention of bacterial and fungal infections in granulocytopenic patients
J Verhoef, M Rozenberg-Arska, A W Dekker
British Journal of Haematology
|
June 1, 1984
The use of intermediate dose cytosine arabinoside (ID Ara-C) in the treatment of acute non-lymphocytic leukaemia in relapse
H C van Prooijen, A W Dekker, K Punt
Page
of 79
Search research articles
Search
Showing results (41-50 of 789) with videos related to
Sort By:
Page
of 79
British Journal of Haematology
|
April 29, 2003
Influence of antithymocyte globulin dose on outcome in cytomegalovirus-seropositive recipients of partially T cell-depleted stem cell grafts from matched-unrelated donors
Ellen Meijer, Adriaan W Dekker, Leo F Verdonck
Clinical Therapeutics
|
January 7, 1998
Factors predicting relapse during maintenance treatment with famotidine in patients with healed reflux esophagitis. Dutch Esophagitis Study Group
I C Wesdorp, W Dekker, H P Festen
Folia Medica Neerlandica
|
January 1, 1971
Pleural metastases of thymoma
J de Jong, W Dekker, A S Groen
Infection
|
May 1, 1983
Colistin and trimethoprim-sulfamethoxazole for the prevention of infection in patients with acute non-lymphocytic leukaemia. Decrease in the emergence of resistant bacteria
M Rozenberg-Arska, A W Dekker, J Verhoef
Clinical Kidney Journal
|
April 17, 2020
A new series of advanced-level research methods papers
Kitty J Jager, Friedo W Dekker, Carmine Zoccali
Klinische Monatsblatter Fur Augenheilkunde
|
May 1, 1996
[Contact glass tonometer]
P W Dekker, H Kanngiesser, Y C Robert
Reviews of Infectious Diseases
|
July 1, 1989
Prevention of infections in granulocytopenic patients by fluorinated quinolones
M Rozenberg-Arska, A W Dekker, J Verhoef
Digestive Diseases and Sciences
|
December 1, 1993
Efficacy of famotidine 20 mg twice a day versus 40 mg twice a day in the treatment of erosive or ulcerative reflux esophagitis
I C Wesdorp, W Dekker, H P Festen
European Journal of Cancer & Clinical Oncology
|
September 1, 1989
Prevention of bacterial and fungal infections in granulocytopenic patients
J Verhoef, M Rozenberg-Arska, A W Dekker
British Journal of Haematology
|
June 1, 1984
The use of intermediate dose cytosine arabinoside (ID Ara-C) in the treatment of acute non-lymphocytic leukaemia in relapse
H C van Prooijen, A W Dekker, K Punt
Page
of 79